Introduction
Anlon Healthcare’s upcoming IPO is drawing investor attention, but all eyes are on one important metric: the Grey Market Premium (GMP). As the Rs 121-crore issue gears up to open on August 26, early signs show there’s currently no grey-market activity surrounding the IPO.
What Is Anlon Healthcare IPO GMP?
The Grey Market Premium (GMP) is the unofficial price at which shares of an IPO are traded before listing. It often reflects investor sentiment, though it is not an official indicator. At present, the Anlon Healthcare IPO GMP is at ₹0, showing no speculative activity in the unofficial market.
Current GMP Status
With a GMP of ₹0, the market is sending a neutral signal. This means there is no premium or discount being placed on the shares before the IPO opens. Such a situation suggests investors are waiting for more clarity before taking positions.
IPO Snapshot
-
Subscription Window: August 26–29, 2025
-
Price Band: ₹86 to ₹91 per share
-
Issue Size: Fresh issue of 1.33 crore shares worth around ₹121 crore
-
Lot Size (Retail): 164 shares (about ₹14,924 at the upper price band)
-
Allotment Date: September 1, 2025
-
Expected Listing: September 3, 2025 on BSE and NSE
What This Means for Investors
The flat GMP indicates no early enthusiasm or concern. Investors may want to wait until subscription data comes in to gauge real demand. While the company’s fundamentals and growth potential may influence decisions, the absence of grey-market action shows the market is cautious at this stage.
Company Background
Anlon Healthcare, founded in 2013, is based in Gujarat and focuses on manufacturing APIs, pharmaceutical intermediates, and nutraceuticals. It operates a WHO-GMP and ISO-certified facility and has reported strong financial growth in recent years, with significant increases in both revenue and profit.
Risk Disclaimer
Disclaimer: Grey-Market Premium (GMP) is based on informal market activity and does not reflect official pricing. Investing should not be based solely on GMP or market chatter. Please consult a qualified financial advisor before making investment decisions. All investments are subject to risk.
